1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/15/2024 | SYK | Buy Now | Stryker | $354.08 | 1.67% | RBC Capital | Shagun Singh | → $360 | Reiterates | Outperform → Outperform | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | 1.67% | RBC Capital | Shagun Singh | $345 → $360 | Maintains | Outperform | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | 2.24% | Citigroup | Joanne Wuensch | $340 → $362 | Maintains | Buy | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | -2.56% | Truist Securities | Richard Newitter | $330 → $345 | Maintains | Hold | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | -1.72% | Roth MKM | Jason Wittes | $345 → $348 | Maintains | Buy | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | 1.67% | Canaccord Genuity | Kyle Rose | → $360 | Upgrade | Hold → Buy | Get Alert |
01/31/2024 | SYK | Buy Now | Stryker | $354.08 | 2.8% | Wells Fargo | Larry Biegelsen | $336 → $364 | Maintains | Overweight | Get Alert |
01/12/2024 | SYK | Buy Now | Stryker | $354.08 | -2.56% | RBC Capital | Shagun Singh | $315 → $345 | Maintains | Outperform | Get Alert |
12/22/2023 | SYK | Buy Now | Stryker | $354.08 | -9.62% | Truist Securities | Richard Newitter | $300 → $320 | Maintains | Hold | Get Alert |
12/04/2023 | SYK | Buy Now | Stryker | $354.08 | -9.62% | Morgan Stanley | Drew Ranieri | $300 → $320 | Maintains | Equal-Weight | Get Alert |
11/09/2023 | SYK | Buy Now | Stryker | $354.08 | -2.56% | Roth MKM | Jason Wittes | → $345 | Reiterates | Buy → Buy | Get Alert |
11/09/2023 | SYK | Buy Now | Stryker | $354.08 | -16.12% | UBS | Danielle Antalffy | $289 → $297 | Maintains | Neutral | Get Alert |
11/06/2023 | SYK | Buy Now | Stryker | $354.08 | -15.27% | Truist Securities | Richard Newitter | $270 → $300 | Maintains | Hold | Get Alert |
10/20/2023 | SYK | Buy Now | Stryker | $354.08 | -2.56% | Roth MKM | Jason Wittes | → $345 | Initiates | → Buy | Get Alert |
10/02/2023 | SYK | Buy Now | Stryker | $354.08 | -6.8% | Citigroup | Joanne Wuensch | $342 → $330 | Maintains | Buy | Get Alert |
09/05/2023 | SYK | Buy Now | Stryker | $354.08 | -11.04% | B of A Securities | Travis Steed | → $315 | Upgrade | Neutral → Buy | Get Alert |
08/17/2023 | SYK | Buy Now | Stryker | $354.08 | -8.21% | RBC Capital | Shagun Singh | → $325 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2023 | SYK | Buy Now | Stryker | $354.08 | -15.27% | Morgan Stanley | Drew Ranieri | $295 → $300 | Maintains | Equal-Weight | Get Alert |
08/07/2023 | SYK | Buy Now | Stryker | $354.08 | -5.39% | Barclays | Matt Miksic | $321 → $335 | Maintains | Overweight | Get Alert |
The latest price target for Stryker (NYSE: SYK) was reported by RBC Capital on February 15, 2024. The analyst firm set a price target for $360.00 expecting SYK to rise to within 12 months (a possible 1.67% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Stryker (NYSE: SYK) was provided by RBC Capital, and Stryker reiterated their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stryker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stryker was filed on February 15, 2024 so you should expect the next rating to be made available sometime around February 15, 2025.
While ratings are subjective and will change, the latest Stryker (SYK) rating was a reiterated with a price target of $0.00 to $360.00. The current price Stryker (SYK) is trading at is $354.08, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.